REPLReplimune Group, Inc.
- Market cap
- $1.08B
- as of 2026-10-23
- Latest close
- $11.46
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-17
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Astley-Sparke Philip | Aug 20 | Aug 24 | G | 50,000 | $0.00 | $0 | 1,362,414 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Aug 17 | Aug 19 | S | 9,256 | $14.28 | Sale −$132,176 | 215,852 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Aug 10 | Aug 12 | S | 7,632 | $12.97 | Sale −$98,987 | 99,425 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Aug 10 | Aug 12 | S | 11,447 | $12.97 | Sale −$148,468 | 224,215 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Aug 10 | Aug 12 | S | 11,448 | $12.97 | Sale −$148,481 | 225,108 | No | Form 4 |
| Patel SushilChief Executive Officer | Aug 10 | Aug 12 | S | 39,341 | $12.97 | Sale −$510,253 | 708,151 | No | Form 4 |
| Baker Felix | Aug 11 | Aug 11 | P · derivative | 126,394 | $12.06 | Purchase +$1,524,312 | 126,394 | No | Form 4 |
| Baker Felix | Aug 11 | Aug 11 | P · derivative | 2,609,946 | $12.06 | Purchase +$31,475,949 | 2,609,946 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Jun 1 | Jun 3 | S | 12,000 | $9.24 | Sale −$110,880 | 180,962 | Yes | Form 4 |
| Hill Emily LuisaChief Financial Officer | May 18 | May 20 | S | 7,812 | $5.08 | Sale −$39,685 | 236,556 | No | Form 4 |
| Patel SushilChief Executive Officer | May 18 | May 20 | S | 37,324 | $5.08 | Sale −$189,606 | 747,492 | No | Form 4 |
| Astley-Sparke Philip | May 18 | May 20 | S | 17,657 | $5.08 | Sale −$89,698 | 1,412,414 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | May 18 | May 20 | S | 8,626 | $5.08 | Sale −$43,820 | 192,962 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | May 18 | May 20 | S | 7,894 | $5.08 | Sale −$40,102 | 107,057 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | May 18 | May 20 | S | 14,023 | $5.08 | Sale −$71,237 | 235,662 | No | Form 4 |
| Weinand Dieter | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1 | Apr 7 | A | 50,000 | $0.00 | $0 | 244,368 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1 | Apr 7 | A · derivative | 75,000 | $7.61 | $570,750 | 75,000 | No | Form 4 |
| Peeples-Dyer Veleka | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Slattery Joseph P | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Pucci Paolo | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Dhingra Kapil | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1 | Apr 7 | A | 251,240 | $0.00 | $0 | 784,816 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1 | Apr 7 | A · derivative | 376,860 | $7.61 | $2,867,905 | 376,860 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1 | Apr 7 | A | 36,667 | $0.00 | $0 | 114,951 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1 | Apr 7 | A · derivative | 55,000 | $7.61 | $418,550 | 55,000 | No | Form 4 |
| Balachandran Madhavan | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1 | Apr 7 | A | 50,000 | $0.00 | $0 | 249,685 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1 | Apr 7 | A · derivative | 75,000 | $7.61 | $570,750 | 75,000 | No | Form 4 |
| Oliger Christy J. | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Astley-Sparke Philip | Apr 1 | Apr 7 | A | 50,000 | $0.00 | $0 | 1,430,071 | No | Form 4 |
| Astley-Sparke Philip | Apr 1 | Apr 7 | A · derivative | 75,000 | $7.61 | $570,750 | 75,000 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1 | Apr 7 | A | 50,000 | $0.00 | $0 | 201,588 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1 | Apr 7 | A · derivative | 75,000 | $7.61 | $570,750 | 75,000 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Apr 1 | Apr 7 | A · derivative | 44,500 | $7.61 | $338,645 | 44,500 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 2 | Apr 6 | S | 6,500 | $8.01 | Sale −$52,065 | 151,588 | Yes | Form 4 |
| Astley-Sparke Philip | Feb 18 | Feb 20 | G | 25,000 | $0.00 | $0 | 1,380,071 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Dec 19, 2025 | Dec 19, 2025 | A | 10,000 | $0.00 | $0 | 78,284 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Dec 19, 2025 | Dec 19, 2025 | A | 35,000 | $0.00 | $0 | 158,088 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Dec 19, 2025 | Dec 19, 2025 | A | 60,000 | $0.00 | $0 | 194,368 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Dec 19, 2025 | Dec 19, 2025 | A | 60,000 | $0.00 | $0 | 199,685 | No | Form 4 |
| Patel SushilChief Executive Officer | Dec 19, 2025 | Dec 19, 2025 | A | 200,000 | $0.00 | $0 | 533,576 | No | Form 4 |
| Dhingra Kapil | Dec 9, 2025 | Dec 11, 2025 | M | 3,169 | $1.75 | $5,546 | 3,169 | No | Form 4 |
| Dhingra Kapil | Dec 9, 2025 | Dec 11, 2025 | S | 3,169 | $10.40 | Sale −$32,958 | not reported | No | Form 4 |
| Dhingra Kapil | Dec 9, 2025 | Dec 11, 2025 | M · derivative | 3,169 | $1.75 | $5,546 | not reported | No | Form 4 |
| Patel SushilChief Executive Officer | Dec 2, 2025 | Dec 4, 2025 | S | 10,000 | $11.13 | Sale −$111,300 | 333,576 | Yes | Form 4 |
| Xynos KonstantinosChief Medical Officer | Nov 17, 2025 | Nov 19, 2025 | S | 7,248 | $9.10 | Sale −$65,957 | 139,685 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Nov 17, 2025 | Nov 19, 2025 | S | 5,208 | $9.10 | Sale −$47,393 | 123,088 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Aug 15, 2025 | Aug 19, 2025 | S | 9,154 | $5.37 | Sale −$49,157 | 134,368 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | May 20, 2025 | May 22, 2025 | S | 3,749 | $8.05 | Sale −$30,179 | 128,296 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | May 20, 2025 | May 22, 2025 | S | 2,535 | $8.05 | Sale −$20,407 | 143,522 | No | Form 4 |
| Patel SushilChief Executive Officer | May 20, 2025 | May 22, 2025 | S | 25,105 | $8.06 | Sale −$202,346 | 343,576 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | May 20, 2025 | May 22, 2025 | S | 3,287 | $8.05 | Sale −$26,460 | 68,284 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | May 20, 2025 | May 22, 2025 | S | 7,952 | $8.06 | Sale −$64,093 | 146,933 | No | Form 4 |
| Astley-Sparke Philip | May 20, 2025 | May 22, 2025 | S | 32,279 | $8.06 | Sale −$260,169 | 1,405,071 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1, 2025 | Apr 3, 2025 | A | 33,333 | $0.00 | $0 | 71,571 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 50,000 | $8.40 | $420,000 | 50,000 | No | Form 4 |
| Oliger Christy J. | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1, 2025 | Apr 3, 2025 | A | 45,000 | $0.00 | $0 | 132,045 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 67,500 | $8.40 | $567,000 | 67,500 | No | Form 4 |
| Weinand Dieter | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1, 2025 | Apr 3, 2025 | A | 45,000 | $0.00 | $0 | 146,057 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 67,500 | $8.40 | $567,000 | 67,500 | No | Form 4 |
| Slattery Joseph P | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Dhingra Kapil | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1, 2025 | Apr 3, 2025 | A | 45,000 | $0.00 | $0 | 154,885 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 67,500 | $8.40 | $567,000 | 67,500 | No | Form 4 |
| Balachandran Madhavan | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Pucci Paolo | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1, 2025 | Apr 3, 2025 | A | 166,667 | $0.00 | $0 | 368,681 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 250,000 | $8.40 | $2,100,000 | 250,000 | No | Form 4 |
| Peeples-Dyer Veleka | Apr 1, 2025 | Apr 3, 2025 | A · derivative | 32,000 | $8.40 | $268,800 | 32,000 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 64,000 | $12.29 | $786,560 | 64,000 | No | Form 4 |
| Baker Bros. Advisors (GP) LLC | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 64,000 | $12.29 | $786,560 | 64,000 | No | Form 4 |
| Patel SushilChief Executive Officer | Dec 16, 2024 | Dec 18, 2024 | S | 10,000 | $12.42 | Sale −$124,200 | 202,014 | Yes | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Nov 18, 2024 | Nov 20, 2024 | S | 5,207 | $10.78 | Sale −$56,131 | 87,045 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Nov 18, 2024 | Nov 20, 2024 | S | 7,246 | $10.78 | Sale −$78,112 | 109,885 | No | Form 4 |
| Balachandran Madhavan | Sep 4, 2024 | Sep 5, 2024 | A · derivative | 64,000 | $10.44 | $668,160 | 64,000 | No | Form 4 |
| Astley-Sparke PhilipExecutive Chairman | Aug 30, 2024 | Aug 30, 2024 | G | 50,000 | $0.00 | $0 | 1,437,350 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Aug 16, 2024 | Aug 19, 2024 | S | 8,938 | $10.18 | Sale −$90,989 | 101,057 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Jun 7, 2024 | Jun 10, 2024 | S | 15,881 | $7.50 | Sale −$119,108 | 117,131 | Yes | Form 4 |
| Xynos KonstantinosChief Medical Officer | May 16, 2024 | May 20, 2024 | S | 6,367 | $6.47 | Sale −$41,194 | 133,012 | No | Form 4 |
| Patel SushilChief Executive Officer | May 16, 2024 | May 20, 2024 | S | 20,194 | $6.47 | Sale −$130,655 | 212,014 | No | Form 4 |
| Coffin Robert | May 16, 2024 | May 20, 2024 | S | 11,464 | $6.47 | Sale −$74,172 | 1,821,872 | No | Form 4 |
| Astley-Sparke PhilipExecutive Chairman | May 16, 2024 | May 20, 2024 | S | 37,928 | $6.47 | Sale −$245,394 | 1,487,350 | No | Form 4 |
| Love ColinChief Operating Officer | May 16, 2024 | May 20, 2024 | S | 17,615 | $6.47 | Sale −$113,969 | 777,345 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | May 16, 2024 | May 20, 2024 | S | 2,298 | $6.47 | Sale −$14,868 | 38,238 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | May 16, 2024 | May 20, 2024 | S | 2,218 | $6.47 | Sale −$14,350 | 92,252 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1, 2024 | Apr 3, 2024 | A | 17,775 | $0.00 | $0 | 40,536 | No | Form 4 |
| Schwendenman AndrewChief Accounting Officer | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 53,325 | $7.73 | $412,202 | 53,325 | No | Form 4 |
| Levitsky Hyam | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Oliger Christy J. | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1, 2024 | Apr 3, 2024 | A | 22,225 | $0.00 | $0 | 94,470 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 66,675 | $7.73 | $515,398 | 66,675 | No | Form 4 |
| Weinand Dieter | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Slattery Joseph P | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1, 2024 | Apr 3, 2024 | A | 26,665 | $0.00 | $0 | 109,995 | No | Form 4 |
| Hill Emily LuisaChief Financial Officer | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 80,000 | $7.73 | $618,400 | 80,000 | No | Form 4 |
| Dhingra Kapil | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1, 2024 | Apr 3, 2024 | A | 26,665 | $0.00 | $0 | 139,379 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 80,000 | $7.73 | $618,400 | 80,000 | No | Form 4 |
| Pucci Paolo | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1, 2024 | Apr 3, 2024 | A | 83,335 | $0.00 | $0 | 232,208 | No | Form 4 |
| Patel SushilChief Executive Officer | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 250,000 | $7.73 | $1,932,500 | 250,000 | No | Form 4 |
| Peeples-Dyer Veleka | Apr 1, 2024 | Apr 3, 2024 | A · derivative | 32,000 | $7.73 | $247,360 | 32,000 | No | Form 4 |
| Sarchi ChristopherChief Commercial Officer | Nov 16, 2023 | Nov 17, 2023 | S | 5,255 | $10.92 | Sale −$57,385 | 72,245 | No | Form 4 |
| Xynos KonstantinosChief Medical Officer | Nov 16, 2023 | Nov 17, 2023 | S | 7,313 | $10.92 | Sale −$79,858 | 112,714 | No | Form 4 |